HIV

In 3 easy steps Reveal HIV instantly detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma. The quality and performance of Reveal HIV is second to none with a sensitivity of 99.8% and a specificity of 99.7%.

This test, available in three formats, is suited for a broad range of testing environments from the point-of-care to the laboratory. Testing applications for Reveal HIV include public health programs, Voluntary Testing & Counselling Centers (VCTs), pharmacies, physician offices, immigration screening, occupational exposures, convenience care clinics, correctional facilities, and more.

The availability of Reveal HIV products may vary by country. Scroll down for more product information.

REVEAL G4 – USA

The FDA-approved Reveal® G4 is the next generation of rapid testing for HIV using MedMira’s patented Rapid Vertical Flow (RVF) Technology™.

Now able to test fingerstick and venipuncture whole blood, Reveal G4 helps healthcare providers test patients not only in laboratories and hospitals but also in point-of-care settings.

Works with serum, plasma, and venipuncture or fingerstick whole blood specimens.

Simple procedure with instant, easy-to-interpret results.

Built-in procedural and reagent control line.

Room-temperature storage.

No timers or specialized equipment needed.

External test controls available as an accessory*

*Reveal G4 test controls are designed for use in customer quality assurance practices, stored at room temperature until ready for use. Each vial is sufficient to perform five Reveal G4 tests.

REVEAL HIV – CANADA

In Canada, Reveal Rapid HIV Antibody Test is approved by Health Canada for serum and plasma specimens and laboratory use only. The test is used by Canadian hospitals, laboratories, sexual health clinics, and the Canadian Armed Forces.

Reveal Rapid HIV Antibody Test is available in the following format:

Cat. No. 815311000416
Qty. 30 tests per box
This format is ideally suited for laboratories using serum and plasma specimens, and batch testing.

Disclaimer: The Canadian public should be aware that the sale of MedMira products in Canada is governed and controlled by the Health Products and Food Branch of Health Canada. Therefore, Canadian residents are advised that certain statements made on this website do not apply to the products that MedMira offers for sale in Canada.

LEARN MORE >

REVEAL HIV – EUROPEAN UNION (CE MARK)

Reveal Rapid HIV Test is approved for sale in the European Union (CE Mark) for POC and laboratory use. We work with a network of sales and marketing and distribution partners in the region to deliver Reveal HIV. Reveal Rapid HIV Test is available in three product formats as follows:

Point-of-Care: This format includes a test tray in each pouch and is ideally suited to testing at the point of patient care, settings such as mobile clinics requiring a portable and all-in-one testing solution.
Cat. No. 815311000577
Qty. 20 tests per box

CHINA & ASIA PACIFIC

MedMira Rapid HIV Test is designed to detect antibodies to HIV-1 and HIV-2, and can be used in a wide range of testing environments from clinical laboratories to mobile testing clinics in developing countries to point-of-care testing in hospitals.

The MedMira Rapid HIV Test is approved for sale in the People’s Republic of China by the State Food and Drug Administration. It is the first whole blood rapid HIV test approved for sale in P.R. China.

MedMira Rapid HIV Test Laboratory format uses whole blood, serum or plasma specimens and is volume packaged for large scale research and public health testing programs.

MedMira Rapid HIV Test Point-of-Care format is sold in packages of single test kits with all the necessary components inside one pouch. This format uses whole blood, serum or plasma specimens and is ideal for doctors’ offices, mobile testing clinics, resource limited settings and hospitals that require smaller numbers of tests be available in various departments for point-of-care testing.

DISTRIBUTED BY >

INTERNATIONAL MARKETS

LATIN AMERICA & THE CARIBBEAN

HIV is a major healthcare challenge in Latin America & the Caribbean. National and local governments as well as international humanitarian agencies in the region are beginning to work on prevention and control initiatives that include large scale public health screening programs as well as routine testing in healthcare facilities.

The product is currently registered for sale with in Belize, Colombia, Costa Rica, Panama, and Venezuela.

AFRICA

According to UNAIDS, in 2010 there were 22.9 million people living with HIV/AIDS in Sub-Saharan Africa. Governments and humanitarian organizations are undertaking large scale testing initiatives in order to prevent and control the further spread of this disease.

MIDDLE EAST

According to the UN Population Fund the Middle East and North Africa are among to the top regions with the fastest growing HIV epidemics. HIV/AIDS has long been a taboo topic in many parts of this region, however, many governments and international organizations are beginning to implement public programs to promote testing and knowing your HIV status.

International Formats & Ordering Information

Point-of-Care: Ideally suited to testing at the point of patient care, settings such as mobile clinics requiring portable and all-in-one testing solution.
Cat. No. 815311007460
Qty. 20 tests per box